View of Rhabdomyolysis due to interactions between CDK4/6 inhibitors and statins during breast cancer treatment: a case-based systematic review

Return to Article Details Rhabdomyolysis due to interactions between CDK4/6 inhibitors and statins during breast cancer treatment: a case-based systematic review Download Download PDF